Evidence map›Paper›PMID 23906882›Full record

ArticleCold Spring Harbor perspectives in medicine2013

Origin and biology of the allogeneic response.

Fadi G Lakkis, Robert I Lechler

Abstract read
In one paragraph

Article in Cold Spring Harbor perspectives in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Biochemistry and biophysics reports · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Failing Heart Transplants and Rejection-A Cellular Perspective.Journal of cardiovascular development and disease · 2021
    Review
  17. The role of self-peptides in direct T cell allorecognition.The Journal of clinical investigation · 2021
    Article
  18. Article
  19. Article
  20. Taking T-Cell Oncotherapy Off-the-Shelf.Trends in immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fadi G LakkisThomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15238, USA. lakkisf@upmc.edu
Robert I Lechler

Funding

Medical Research Council MR/J006742/1
6 · The paper itself

Abstract

The recognition by the immune system of nonself determinants on cells, tissues, or organs transplanted between genetically disparate members of the same species can lead to a potent allogeneic response that is responsible for rejection. We review here fundamental concepts that underlie the origins and biology of allorecognition in the mammalian immune system. We examine why and how T cells are alloreactive and discuss emerging evidence of allorecognition by innate immune cells. The nature of T cells (naïve vs. memory) and the alloantigen presentation pathways (direct, indirect, and semidirect) that initiate the allogeneic response are outlined.

Indexed as

Immunity, InnateAnimalsAntigen PresentationGraft RejectionHistocompatibility AntigensHumansImmunosuppression TherapyIsoantigensMammalsT-LymphocytesHistocompatibility AntigensIsoantigens

Identifiers

PMID23906882
PMCPMC3721272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.